title: Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects.
abstract: Azithromycin (AZI), a broad-spectrum antibiotic, accumulates in polymorphonuclear cells and peripheral blood mononuclear cells. The distribution of AZI in proinflammatory cells may be important to the anti-inflammatory properties. Previous studies have described plasma AZI pharmacokinetics. The objective of this study was to describe the pharmacokinetics of AZI in whole blood (concentration in whole blood [Cb]) and plasma (concentration in plasma [Cp]) of healthy subjects. In this study, 12 subjects received AZI (500 mg once a day for 3 days). AZI Cb and Cp were quantified in serial samples collected up to 3 weeks after the last dose and analyzed using noncompartmental and compartmental methods. After the last dose, Cb was greater than Cp. Importantly, Cb, but not Cp, was quantifiable in all but one subject at 3 weeks. The blood area under the curve during a 24-h dosing interval (AUC24) was ∼2-fold greater than the plasma AUC24, but simulations suggested that Cb was not at steady state by day 3. Upon exploration of numerous models, an empirical 3-compartment model adequately described Cp and Cb, but Cp was somewhat underestimated. Intercompartmental clearance (CL; likely representing cells) was lower than apparent oral CL (18 versus 118 liters/h). Plasma, peripheral, and cell compartmental volumes were 439 liters, 2,980 liters, and 3,084 liters, respectively. Interindividual variability in CL was low (26.2%), while the volume of distribution variability was high (107%). This is the first report to describe AZI Cb in healthy subjects, the distribution parameters between Cp and Cb, and AZI retention in blood for up to 3 weeks following 3 daily doses. The model can be used to predict Cb from Cp for AZI under various dosing regimens. (This study has been registered at ClinicalTrials.gov under registration no. NCT01026064.).
authors: Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. teodora.x.pene-dumitrescu@gsk.com
authors: T
authors: T
authors: Pene Dumitrescu
authors: T
authors: T
authors: Anic-Milic
authors: K
authors: K
authors: Oreskovic
authors: J
authors: J
authors: Padovan
authors: K L R
authors: KL
authors: Brouwer
authors: P
authors: P
authors: Zuo
authors: V D
authors: VD
authors: Schmith
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000097:blood*; D017963:Azithromycin / Q000097:blood*; D006207:Half-Life; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects; D010949:Plasma; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin
references: Antimicrob Agents Chemother. 1996 Jan;40(1):75-9
references: 8787883
references: Am J Respir Crit Care Med. 2005 Sep 15;172(6):772-5
references: 15976371
references: Pharmacol Ther. 2008 Mar;117(3):393-405
references: 18289694
references: Antimicrob Agents Chemother. 2007 Jan;51(1):103-9
references: 17060516
references: Transplantation. 2008 Jan 15;85(1):36-41
references: 18192909
references: J Cyst Fibros. 2010 Jan;9(1):17-23
references: 19818694
references: J Cyst Fibros. 2008 Jan;7(1):79-84
references: 17599845
references: Clin Pharm. 1992 Feb;11(2):137-52
references: 1312921
references: Pulm Pharmacol Ther. 2010 Jun;23(3):200-7
references: 20025989
references: Int J Tissue React. 1994;16(5-6):211-20
references: 7558665
references: Chest. 2004 Feb;125(2 Suppl):70S-78S
references: 14872003
references: Ther Drug Monit. 2006 Apr;28(2):219-25
references: 16628134
references: PLoS Clin Trials. 2006 Jun;1(2):e11
references: 16871333
references: J Fam Pract. 1995 Oct;41(4):345-51
references: 7561707
references: J Antimicrob Chemother. 1993 Mar;31 Suppl C:1-9
references: 7683018
references: Respir Med. 2008 Nov;102(11):1643-53
references: 18701270
references: AAPS J. 2009 Jun;11(2):371-80
references: 19452283
references: Antimicrob Agents Chemother. 1996 Nov;40(11):2582-5
references: 8913469
references: Respirology. 2012 Jul;17(5):802-7
references: 22288725
references: JAMA. 2003 Oct 1;290(13):1749-56
references: 14519709
references: Clin Ther. 1996 Jan-Feb;18(1):56-72; discussion 55
references: 8851453
references: Thorax. 2006 Oct;61(10):895-902
references: 16809416
references: Lancet. 2002 Sep 28;360(9338):978-84
references: 12383667
references: Am J Respir Crit Care Med. 2008 Jul 15;178(2):139-48
references: 18420960
references: Eur Respir J. 2011 Jan;37(1):164-72
references: 20562124
references: Antimicrob Agents Chemother. 1990 Jun;34(6):1056-60
references: 2168141
references: Antimicrob Agents Chemother. 2005 Dec;49(12):5013-7
references: 16304166
references: J Am Board Fam Med. 2012 Jul-Aug;25(4):442-59
references: 22773713
references: J Cyst Fibros. 2003 Jun;2(2):69-71
references: 15463852
references: Curr Med Chem. 2008;15(7):716-23
references: 18336286
references: Am J Respir Crit Care Med. 2006 Sep 1;174(5):566-70
references: 16741151
references: Allergy Asthma Proc. 2007 Mar-Apr;28(2):194-8
references: 17479604
references: Int J Clin Pharmacol Ther. 1994 Jul;32(7):356-60
references: 7952797
references: Ann Pharmacother. 1992 Oct;26(10):1253-61
references: 1330097
references: Respir Med. 2008 Oct;102(10):1494-6
references: 18653323
references: JAMA. 2010 May 5;303(17):1707-15
references: 20442386
references: Int J Antimicrob Agents. 2008 Jan;31(1):12-20
references: 17935949
references: Thorax. 2004 Jun;59(6):540-1
references: 15170047
references: AAPS J. 2009 Sep;11(3):558-69
references: 19649712
references: Antimicrob Agents Chemother. 1987 Dec;31(12):1948-54
references: 2830841
references: J Infect Dis. 2002 Jun 1;185(11):1631-6
references: 12023769
references: Treat Respir Med. 2005;4(2):117-22
references: 15813663
references: J Leukoc Biol. 2012 Feb;91(2):229-43
references: 22131344
references: Rev Esp Quimioter. 2000 Dec;13(4):379-83
references: 11498704
references: Br J Pharmacol. 2012 Mar;165(5):1348-60
references: 21726210
references: Antimicrob Agents Chemother. 1994 Oct;38(10):2449-51
references: 7840585
references: Eur Respir J. 2007 Sep;30(3):487-95
references: 17537764
references: J Allergy Clin Immunol. 2008 Dec;122(6):1138-1144.e4
references: 18951618
references: N Engl J Med. 2011 Aug 25;365(8):689-98
references: 21864166
references: Clin Drug Investig. 1998;15(2):159-67
references: 18370479
references: Antimicrob Agents Chemother. 1989 Mar;33(3):277-82
references: 2543276
references: Thorax. 2002 Mar;57(3):212-6
references: 11867823
references: J Cyst Fibros. 2005 Mar;4(1):35-40
references: 15752679
references: J Antimicrob Chemother. 1990 Jan;25 Suppl A:73-82
references: 2154441